KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RMD) Interest & Investment Income (2016 - 2025)

Resmed (RMD) has disclosed Interest & Investment Income for 16 consecutive years, with $7.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income rose 1125.68% year-over-year to $7.9 million, compared with a TTM value of $23.3 million through Dec 2025, up 220.17%, and an annual FY2025 reading of $4.1 million, up 109.0% over the prior year.
  • Interest & Investment Income was $7.9 million for Q4 2025 at Resmed, down from $8.8 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $8.8 million in Q3 2025 and bottomed at -$15.0 million in Q3 2023.
  • Average Interest & Investment Income over 4 years is -$2.1 million, with a median of -$360500.0 recorded in 2021.
  • The sharpest move saw Interest & Investment Income plummeted 76.86% in 2021, then surged 1125.68% in 2025.
  • Year by year, Interest & Investment Income stood at $59000.0 in 2021, then crashed by 23498.31% to -$13.8 million in 2023, then soared by 94.39% to -$775000.0 in 2024, then soared by 1125.68% to $7.9 million in 2025.
  • Business Quant data shows Interest & Investment Income for RMD at $7.9 million in Q4 2025, $8.8 million in Q3 2025, and $5.8 million in Q2 2025.